Lemborexant in Delayed Sleep Phase Syndrome | MicrobiomeTrials← Back to trialsNCT05463861
Lemborexant in Delayed Sleep Phase Syndrome
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2022-02-01Est. Completion: 2027-05-31
Enrollment target: 86 participants Locations- Stanford Univeristy, Redwood City, California, United States
- University of California San Francisco, San Francisco, California, United States
Other microbiome trials you might be interested in
Metabolic Syndrome
This study aims to evaluate the effectiveness of a multimodal intervention using immersive virtual reality (Virtual-METS…
Terrassa, SpainEst. completion Apr 1, 2027
Bipolar Disorder (BD)
Among psychiatric disorders, bipolar disorder stands out due to its alarmingly high suicide rates. This condition presen…
Lund, SwedenEst. completion Dec 31, 2029